Browse by Academic Unit (A-Z)

A

Abraham, S, Scarcia, M, Bagshaw, R et al. (15 more authors) (2015) A Rac/Cdc42 exchange factor complex promotes formation of lateral filopodia and blood vessel lumen morphogenesis. Nature Communications, 6. 7286. ISSN 2041-1723

Acquaviva, J, He, S, Zhang, C et al. (11 more authors) (2014) FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism. Molecular Cancer Research, 12 (7). 1042 - 1054. ISSN 1541-7786

Ambrose, SR, Gordon, NS, Goldsmith, JC et al. (6 more authors) (2015) Use of Aleuria alantia Lectin Affinity Chromatography to Enrich Candidate Biomarkers from the Urine of Patients with Bladder Cancer. Proteomes, 3 (3). 266 - 282. ISSN 2227-7382

B

Baldia, PH, Maurer, A, Heide, T et al. (7 more authors) (2016) Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup. Oncotarget.

Blick, C, Ramachandran, A, Wigfield, S et al. (8 more authors) (2013) Hypoxia regulates FGFR3 expression via HIF-1α and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer. British Journal of Cancer, 109 (1). pp. 50-59. ISSN 0007-0920

Brennan-Crispi, DM, Hossain, C, Sahu, J et al. (3 more authors) (2015) Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis. Oncotarget, 6 (11). pp. 8593-8605.

Brennan-Crispi, DM, Overmiller, AM, Tamayo-Orrego, L et al. (11 more authors) (2019) Overexpression of Desmoglein 2 in a mouse model of Gorlin syndrome enhances spontaneous basal cell carcinoma formation through STAT3-mediated Gli1 expression. Journal of Investigative Dermatology, 139 (2). pp. 300-307. ISSN 0022-202X

Brownhill, S, Cohen, D and Burchill, S (2014) Proliferation Index: A Continuous Model to Predict Prognosis in Patients with Tumours of the Ewing's Sarcoma Family. PLOS ONE, 9 (8). e104106. ISSN 1932-6203

Brownhill, SC, Taylor, C and Burchill, SA (2007) Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT. British Journal of Cancer, 96 (12). pp. 1914-1923. ISSN 0007-0920

Bryan, RT, Regan, HL, Pirrie, SJ et al. (6 more authors) (2015) Protein shedding in urothelial bladder cancer: Prognostic implications of soluble urinary EGFR and EpCAM. British Journal of Cancer, 112 (6). 1052 - 1058. ISSN 0007-0920

Bunney, TD, Wan, S, Thiyagarajan, N et al. (8 more authors) (2015) The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study. EBiomedicine, 2 (3). 194 - 204.

Burchill, SA, Bradbury, MF, Pittman, K et al. (3 more authors) (1995) Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. British Journal of Cancer, 71 (2). pp. 278-281. ISSN 0007-0920

Burchill, SA, Lewis, IJ and Selby, P (1999) Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells. British Journal of Cancer, 79 (5-6). pp. 971-977. ISSN 0007-0920

Burchill, SA, Perebolte, L, Johnston, C et al. (2 more authors) (2002) Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells. British Journal of Cancer, 86 (1). pp. 102-109. ISSN 0007-0920

Burghel, GJ, Hurst, CD, Watson, CM et al. (4 more authors) (2015) Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms. BioMed Research International, 2015. 478017. ISSN 2314-6133

C

Cooper, F, Overmiller, AM, Loder, A et al. (8 more authors) (2018) Enhancement of cutaneous wound healing by Dsg2 augmentation of uPAR secretion. Journal of Investigative Dermatology, 138 (11). p. 2470. ISSN 0022-202X

D

De Faveri, LE, Hurst, CD orcid.org/0000-0001-7719-1325, Platt, FM et al. (5 more authors) (2013) Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer. British Journal of Cancer, 108 (6). pp. 1368-1377. ISSN 0007-0920

De Faveri, LE, Hurst, CD, Roulson, J et al. (4 more authors) (2015) Polycomb repressor complex 1 member, BMI1 contributes to urothelial tumorigenesis through p16-independent mechanisms. Translational Oncology, 8 (5). pp. 387-399. ISSN 1944-7124

Di Martino, E, Alder, O orcid.org/0000-0002-7975-9727, Hurst, CD orcid.org/0000-0001-7719-1325 et al. (1 more author) (2019) ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer. Scientific Reports, 9. ARTN: 5740. ISSN 2045-2322

Di Martino, E, Kelly, G, Roulson, JA et al. (1 more author) (2015) Alteration of cell-cell and cell-matrix adhesion in urothelial cells: An oncogenic mechanism for mutant FGFR3. Molecular Cancer Research, 13 (1). 138 - 148. ISSN 1541-7786

Di Martino, E, Taylor, CF, Roulson, J-A et al. (1 more author) (2013) An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer. Genes Chromosomes and Cancer, 52 (9). pp. 860-871. ISSN 1045-2257

Di Martino, E, Tomlinson, DC orcid.org/0000-0003-4134-7484, Williams, SV et al. (1 more author) (2016) A place for precision medicine in bladder cancer: targeting the FGFRs. Future Oncology, 12 (19). pp. 2243-2263. ISSN 1479-6694

F

Foth, M, Ismail, NFB, Kung, JSC et al. (7 more authors) (2018) FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation. Journal of Pathology, 246 (3). pp. 331-343. ISSN 0022-3417

Fultang, L, Gamble, LD, Gneo, L et al. (20 more authors) (2019) Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma. Cancer Research, 79 (3). pp. 611-624. ISSN 0008-5472

G

Giedl, J, Rogler, A, Wild, A et al. (9 more authors) (2016) TERT Core Promotor Mutations In Early-Onset Bladder Cancer. Journal of Cancer, 7 (8). pp. 915-920. ISSN 1837-9664

H

Herrera-Abreu, MT, Pearson, A, Campbell, J et al. (4 more authors) (2013) Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer. Cancer Discovery, 3 (9). 1058 - 1071. ISSN 2159-8274

Hurst, CD orcid.org/0000-0001-7719-1325, Alder, O orcid.org/0000-0002-7975-9727, Platt, FM et al. (15 more authors) (2017) Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency. Cancer Cell, 32 (5). pp. 701-715. ISSN 1535-6108

Hurst, CD and Knowles, MA (2014) Molecular subtyping of invasive bladder cancer: time to divide and rule? Cancer Cell, 25 (2). 135 - 136. ISSN 1535-6108

J

Johnson, PWM, Burchill, SA and Selby, PJ (1995) The molecular detection of circulating tumour cells. British Journal of Cancer, 72 (2). pp. 268-276. ISSN 0007-0920

K

Kim, B, Stephen, SL, Hanby, AM et al. (9 more authors) (2015) Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy. BMC Cancer, 15. 634. ISSN 1471-2407

Knowles, MA and Hurst, CD (2014) Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nature Reviews Cancer, 15 (1). 25 - 41. ISSN 1474-175X

Kovar, H, Alonso, J, Aman, P et al. (34 more authors) (2012) The first European interdisciplinary Ewing sarcoma research summit. Frontiers in Oncology, 2. 54.

L

Lerner, SP, Bajorin, DF, Dinney, CP et al. (32 more authors) (2016) Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer. Bladder Cancer, 2 (2). pp. 165-202. ISSN 2352-3727

P

Papadopoulos, V, Tsapakidis, K, Del Galdo, NAR et al. (6 more authors) (2016) The Prognostic Significance of the Hedgehog Signaling Pathway in Colorectal Cancer. Clinical Colorectal Cancer, 15 (2). pp. 116-127. ISSN 1533-0028

Pashankar, F, Hale, JP, Dang, H et al. (15 more authors) (2016) Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer, 122 (2). pp. 230-237. ISSN 0008-543X

Patani, H, Bunney, TD, Thiyagarajan, N et al. (14 more authors) (2016) Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use. Oncotarget, 7 (17). pp. 24252-24268. ISSN 1949-2553

Pouessel, D, Neuzillet, Y, Mertens, LS et al. (35 more authors) (2016) Tumor Heterogeneity of Fibroblast Growth Factor Receptor 3 (FGFR3) Mutations in Invasive Bladder Cancer: Implications for Peri-Operative anti-FGFR3 Treatment. Annals of Oncology, 27 (7). pp. 1311-1316. ISSN 0923-7534

R

Riley, RD, Abrams, KR, Sutton, AJ et al. (4 more authors) (2003) Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future. British Journal of Cancer, 88 (8). pp. 1191-1198. ISSN 0007-0920

Riobo-Del Galdo, NA orcid.org/0000-0002-8942-7873, Lara Montero, Á and Wertheimer, EV (2019) Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics. Cells, 8 (4). 375. ISSN 2073-4409

Rippaus, N, Taggart, D, Williams, J et al. (4 more authors) (2016) Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases. Oncotarget, 7 (27). pp. 41473-41487.

Ross, RL, McPherson, HR, Kettlewell, L et al. (4 more authors) (2016) PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma. BMC Cancer, 16. 553. ISSN 1471-2407

Roundhill, EA and Burchill, SA (2012) Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria. British Journal of Cancer, 106 (6). pp. 1224-1233. ISSN 0007-0920

Roundhill, EA, Jabri, S and Burchill, SA (2019) ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells. Cancer Letters, 453. pp. 142-157. ISSN 0304-3835

S

Sethi, N, Prowse, S and Ghosh, S (2012) Hypocalcaemia following total thyroidectomy. Annals of Otology, Rhinology and Laryngology, 121 (12). 827 - 828 (1). ISSN 0003-4894

Stadler, LK, Tomlinson, DC, Lee, T et al. (2 more authors) (2014) The use of a neutral peptide aptamer scaffold to anchor BH3 peptides constitutes a viable approach to studying their function. Cell Death and Disease, 5. e1037. e1037 - e1037. ISSN 2041-4889

Sturla, L-M, Merrick, AE and Burchill, SA (2003) FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. British Journal of Cancer, 89 (7). pp. 1276-1284. ISSN 0007-0920

T

Trerotola, M, Ganguly, KK, Fazli, L et al. (12 more authors) (2015) Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts. Oncotarget, 6 (16). pp. 14318-14328.

Turo, R, Harnden, P, Thygesen, H et al. (5 more authors) (2015) FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases. Journal of Urology, 193 (1). 325 - 330. ISSN 0022-5347

W

Weber, MR, Zuka, M, Lorger, M et al. (10 more authors) (2016) Activated tumor cell integrin αVβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream. Thrombosis Research, 140 (1). S27-S36. ISSN 0049-3848

White, DE and Burchill, SA (2010) Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours. British Journal of Cancer, 103 (9). pp. 1380-1390. ISSN 1532-1827

Wilson, EB, Meade, JL, Davison, AC et al. (2 more authors) (2014) Transforming growth factor-beta globally and specifically inhibits natural killer cells. In: Immunology. British Society for Immunology Annual Congress 2014, 01-04 Dec 2014, Brighton, UK. Wiley , 60 - 60.

Z

Zhang, YF, Jeffrey, S, Burchill, SA et al. (3 more authors) (1998) Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. British Journal of Cancer, 78 (9). pp. 1141-1146. ISSN 0007-0920